Kiniksa Pharmaceuticals International, plc (KNSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.06B |
| Enterprise Value | 2.9B |
| P/E Ratio | 64.73 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 6.32 |
| Price/Book Ratio | 8.01 |
| Enterprise/Revenue | 6.08 |
| Enterprise/EBITDA | 42.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
| Revenue | 677.56M |
| Revenue/Share | 9.85 |
| Gross Profit | 370.15M |
| EBITDA | 90.42M |
| Net Income | 59.01M |
| Diluted EPS | 0.75 |
| Total Cash | 468.09M |
| Total Cash/Share | 6.12 |
| Total Debt | 9.03M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.79 |
| Book Value Per Share | 7.92 |
| 52-Week Change | 120.28 |
| 52-Week High | 67.53 |
| 52-Week Low | 26.27 |
| Moving Average 50 Days | 55.78 |
| Moving Average 200 Days | 45.79 |
| Average Volume | 821,406 |
| Shares Outstanding | 75.17M |
| % Held by Institutions | 61.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |